PharmaCorp Rx Inc. (TSXV:PCRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.4750
0.00 (0.00%)
Oct 1, 2025, 11:59 AM EDT

PharmaCorp Rx Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-0.36-1.01-0.47-0.52-0.08
Depreciation & Amortization
0.640.29---
Stock-Based Compensation
0.280.28-0.39-
Other Operating Activities
-0.18-0.14---
Change in Accounts Receivable
-0.32-0---
Change in Inventory
-0.270.11---
Change in Accounts Payable
0.930.5--0.010.08
Change in Income Taxes
0.010---
Change in Other Net Operating Assets
-0.340.1-0.050.02-
Operating Cash Flow
0.410.12-0.52-0.120
Capital Expenditures
-2.15-0.01---
Cash Acquisitions
-17.96-16.86---
Investing Cash Flow
-20.1-16.86---
Long-Term Debt Repaid
--0.11---
Net Debt Issued (Repaid)
-0.19-0.11---
Issuance of Common Stock
7.6427.490.0323
Other Financing Activities
----0.13-0.06
Financing Cash Flow
7.4427.380.031.872.94
Net Cash Flow
-12.2410.64-0.491.752.94
Free Cash Flow
-1.730.12-0.52-0.120
Free Cash Flow Margin
-12.45%2.04%---
Free Cash Flow Per Share
-0.010.00-0.03-0.01-
Levered Free Cash Flow
-2.45-0.54-0.410.04-
Unlevered Free Cash Flow
-2.43-0.54-0.410.04-
Change in Working Capital
0.020.71-0.050.010.08
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.